We are a regional biopharma company specializing in the commercialization of innovative biopharmaceutical products targeting severe and rare diseases.
Headquartered in Nicosia, Genesis Pharma (Cyprus) Ltd was founded with the mission to ensure that patients suffering from severe and rare diseases, have direct access to innovative branded medicines. Guided by this same mission, the company is also operating through local subsidiaries in Sofia, Bulgaria (Genesis Pharma Bulgaria EOOD), Bucharest in Romania (Genesis Biopharma Romania SRL) and Zagreb in Croatia (Genesis Pharma Adriatic d.o.o.) with the latter entity acting as a hub-office covering the Adriatic region and Malta.
The company has established long-term alliances with leading global biopharma companies and is responsible for a unique portfolio of innovative biopharmaceuticals, most of which target diseases with high unmet medical need, in the therapeutic areas of Haematology, Oncology, Central Nervous System, Inflammation & Immunology, Nephrology, Rheumatology, Dermatology as well as Rare Genetic Inherited diseases.
Genesis Pharma (Cyprus) Ltd is affiliated (sister company) to GENESIS Pharma SA in Athens, Greece.